Total Payments
$5,434
2024 Payments
$1,416
Companies
34
Transactions
327
Medicare Patients
761
Medicare Billing
$40,553
Payment Breakdown by Category
Food & Beverage$5,434 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,434 | 327 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $940.64 | 47 | $0 (2024) |
| GlaxoSmithKline, LLC. | $613.24 | 48 | $0 (2024) |
| PFIZER INC. | $472.13 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $459.78 | 18 | $0 (2024) |
| Lilly USA, LLC | $456.68 | 31 | $0 (2024) |
| Novo Nordisk Inc | $418.93 | 27 | $0 (2024) |
| Amgen Inc. | $281.08 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $258.14 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $172.25 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $147.30 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,416 | 68 | AstraZeneca Pharmaceuticals LP ($335.61) |
| 2023 | $1,261 | 84 | GlaxoSmithKline, LLC. ($211.86) |
| 2022 | $1,347 | 88 | GlaxoSmithKline, LLC. ($227.28) |
| 2021 | $1,410 | 87 | AbbVie Inc. ($327.75) |
All Payment Transactions
327 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes | ||||||
| 12/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: PAIN | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: VACCINES | ||||||
| 11/18/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO, ZEPBOUND | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 11/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: VACCINES | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: VACCINE | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO, ZEPBOUND | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: VACCINES | ||||||
| 09/16/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Hepatitis B Vaccine | ||||||
| 09/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: PAIN | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: UROLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 148 | 185 | $29,910 | $11,013 |
| 2022 | 4 | 141 | 171 | $27,102 | $9,879 |
| 2021 | 9 | 268 | 318 | $33,017 | $11,773 |
| 2020 | 6 | 204 | 268 | $26,130 | $7,889 |
Total Patients
761
Total Services
942
Medicare Billing
$40,553
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 92 | $16,928 | $6,018 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 59 | $7,608 | $2,834 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $5,205 | $2,132 | 41.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 13 | $169.00 | $28.60 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 78 | $13,884 | $4,793 | 34.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $6,641 | $3,004 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 51 | $6,018 | $1,937 | 32.2% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 13 | 13 | $559.00 | $144.85 | 25.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 84 | $14,952 | $5,760 | 38.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 88 | $10,384 | $3,826 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $2,519 | $1,156 | 45.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 14 | 17 | $969.00 | $285.60 | 29.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 24 | 26 | $2,106 | $274.56 | 13.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 24 | 26 | $884.00 | $202.02 | 22.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 12 | 14 | $560.00 | $126.28 | 22.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 26 | 33 | $396.00 | $99.00 | 25.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 16 | 19 | $247.00 | $42.75 | 17.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 61 | $10,858 | $3,692 | 34.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 77 | 87 | $10,266 | $3,358 | 32.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 26 | 34 | $2,754 | $356.73 | 13.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 22 | 31 | $1,054 | $239.27 | 22.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 14 | 16 | $730.00 | $125.82 | 17.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 25 | 39 | $468.00 | $116.34 | 24.9% |
About Sarah Keith
Sarah Keith is a Family healthcare provider based in Bentonville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2014. The National Provider Identifier (NPI) number assigned to this provider is 1992113294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Keith has received a total of $5,434 in payments from pharmaceutical and medical device companies, with $1,416 received in 2024. These payments were reported across 327 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,434).
As a Medicare-enrolled provider, Keith has provided services to 761 Medicare beneficiaries, totaling 942 services with total Medicare billing of $40,553. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Bentonville, AR
- Active Since 07/30/2014
- Last Updated 07/30/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1992113294
Products in Payments
- UBRELVY (Drug) $634.15
- TRELEGY ELLIPTA (Drug) $433.81
- QULIPTA (Drug) $285.02
- AIRSUPRA (Drug) $274.61
- JARDIANCE (Drug) $244.82
- NURTEC ODT (Drug) $232.25
- EMGALITY (Drug) $205.43
- Ozempic (Drug) $187.20
- BELSOMRA (Drug) $166.82
- ELIQUIS (Drug) $159.99
- Otezla (Drug) $155.78
- Kerendia (Drug) $147.30
- Rybelsus (Drug) $144.36
- TRULICITY (Drug) $138.23
- XIFAXAN (Drug) $127.90
- FARXIGA (Drug) $126.72
- BEXSERO (Biological) $118.22
- Livalo (Drug) $114.30
- PREVNAR 20 (Biological) $108.39
- Aimovig (Biological) $66.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Bentonville
Janice Williams, Apn, APN
Family — Payments: $4,849
Family $4,849
Jaime Holthaus, Aprn, APRN
Family — Payments: $3,723
Family $3,723
Melinda Tucker, Fnp-C, FNP-C
Family — Payments: $3,470
Family $3,470
Tiffany Shanahan, Np-C, NP-C
Family — Payments: $2,429
Family $2,429
Bethany Cook
Family — Payments: $2,275
Family $2,275
Mrs. Linda West, Anp, ANP
Family — Payments: $2,058
Family $2,058